DOUBLE-BLIND COMPARISON OF BUSPIRONE 10 MG BID VERSUS BUSPIRONE-5 MG TID IN GENERALIZED ANXIETY DISORDER

被引：3

作者：

FONTAINE, R ^{[1
]}

NAPOLIELLO, MJ ^{[1
]}

机构：

[1] BRISTOL MYERS SQUIBB, PRINCETON, NJ USA

来源：

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1993年 / 54卷 / 02期

关键词：

D O I：

10.1016/S0011-393X(05)80609-5

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Buspirone, a nonsedative anxiolytic agent, was administered to 40 consecutive outpatients suffering from generalized anxiety disorder. After a washout period, patients were randomly assigned to receive buspirone, either 5 mg three times a day or 10 mg twice a day, for 6 weeks. A significant improvement was found for those receiving 20 mg daily as compared with those on 15 mg daily, but there were more adverse reactions with the 20-mg daily regimen. These findings have clinical implications for optimal treatment of generalized anxiety disorder, and further research should be carried out to assess the optimal dosage of buspirone for the treatment of this disorder.

引用

页码：254 / 261

页数：8

共 50 条

[41] Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or Cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections
Bucko, AD
Hunt, BJ
Kidd, SL
Hom, R
CLINICAL THERAPEUTICS, 2002, 24 (07) : 1134 - 1147
[42] Treatment outcome of tofacitinib dose reduction to 5 mg BID vs remaining on 10 mg BID in patients with Ulcerative Colitis who were in stable remission on 10 mg BID: Updated 30-month data from the double-blind, randomised RIVETING study
Rubin, D. T.
Panes, J.
Torres, J.
Kobayashi, T.
Su, C.
Lawendy, N.
Modesto, I.
Segovia, M.
Gardiner, S.
Wang, W.
Vermeire, S.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 914 - 916
[43] DOUBLE-BLIND COMPARISON OF METAPROTERENOL 10-MG WITH EPHEDRINE IN BRONCHIAL-ASTHMA
EMIRGIL, C
WESSON, C
SOBOL, BJ
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1977, 22 (03): : 368 - 375
[44] A RANDOMIZED, DOUBLE-BLIND COMPARISON OF THE EFFICACY AND SAFETY OF VALDECOXIB 10 mg AND ROFECOXIB 25 mg IN INDIAN PATIENTS WITH OSTEOARTHRITIS
Desai, A.
Jagtap, S.
Ballary, C.
RHEUMATOLOGY, 2004, 43 : 64 - 65
[45] COMPARISON OF THE EFFICACY OF RANITIDINE 300 MG NOCTE AND RANITIDINE 300 MG BID IN THE TREATMENT OF DUODENAL-ULCER - A DOUBLE-BLIND CONTROLLED TRIAL
DOBRILLA, G
DEPRETIS, G
PIAZZI, L
SAGGIORO, A
CHIOZZINI, G
STEELE, A
CLINICAL TRIALS JOURNAL, 1988, 25 (03) : 204 - 210
[46] Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo in generalized anxiety disorder
Stein, D.
Ahokas, A.
Jarema, M.
Avedisova, A. S.
Vavrusova, L.
Chaban, O.
Olivier, V.
Gruget, C.
Picarel-Blanchot, F.
De Bodinat, C.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S601 - S602
[47] Abecarnil for the treatment of generalized anxiety disorder: A placebo-controlled comparison of two dosage ranges of abecarnil and buspirone
Pollack, MH
Worthington, JJ
Manfro, GG
Otto, MW
Zucker, BG
JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 : 19 - 23
[48] DOUBLE-BLIND TRIAL OF TRIAZOLAM 0.5 MG VS NITRAZEPAM 5 MG IN OUTPATIENTS
ELLINGSEN, PA
ACTA PSYCHIATRICA SCANDINAVICA, 1983, 67 (03) : 154 - 158
[49] DOUBLE-BLIND COMPARISON OF AN ACETAMINOPHEN 400 MG CODEINE 25 MG COMBINATION VERSUS ASPIRIN 1000 MG AND PLACEBO IN ACUTE MIGRAINE ATTACK
BOUREAU, F
JOUBERT, JM
LASSERRE, V
PRUM, B
DELECOEUILLERIE, G
CEPHALALGIA, 1994, 14 (02) : 156 - 161
[50] TREATMENT OUTCOME OF TOFACITINIB DOSE REDUCTION TO 5 MG TWICE DAILY (BID) VS REMAINING ON 10 MG BID IN PATIENTS WITH ULCERATIVE COLITIS WHO WERE IN STABLE REMISSION ON 10 MG BID: UPDATED 30 MONTH DATA FROM THE DOUBLE-BLIND, RANDOMIZED RIVETING STUDY
Rubin, David T.
Panes, Julian
Torres, Joana
Kobayashi, Taku
Su, Chinyu
Lawendy, Nervin
Modesto, Irene
Segovia, Michelle
Gardiner, Sean M.
Wang, Wenjin
Vermeire, Severine
GASTROENTEROLOGY, 2023, 164 (06) : S1101 - S1102

← 1 2 3 4 5 →